Select for export PSYCHEDELICS IN PSYCHIATRY - OVERVIEW OF PSILOCYBIN RESEARCH Abstract available at the source but not redistributed here. Read at source. Details DOI 10.31435/ijitss.3(47).2025.3650 Copy citation Copy BibTeX International Journal of Innovative Technologies in Social Science 2025-08-31 Anna Blazhkova, Magdalena Czaja, Hanna Sitka, Sven Solisch, Anna Susłow, Ewa Szczęsna OpenAlex Published psilocybin DepressionEating DisordersNeuroplasticity Randomized Controlled Trial More
Select for export A lexicon for psychedelic research and treatment Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/20503245251380511 Copy citation Copy BibTeX Drug Science Policy and Law 2025-08-31 David Nutt, David Erritzøe, Anne Katrin Schlag, David Luke, Deborah C. Mash, Hiroyuki Uchida OpenAlex Published psilocybin DepressionPharmacologyMicrodosing Clinical Trial More
Select for export Biochemical Insights into Diverse Psilocybe Mushrooms and Their Metabolites as Sources of Neuroactive Agents: A Review Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX Unknown journal 2025-08-31 Sudhakaran G, Chakraborty S, Aung San, Bharti SAK, Csaba V, Valan Arasu M Europe PMC Published psilocybinpsilocin DepressionAnxietyPTSD Review Article More
Select for export Psilocybin with psychotherapeutic support for treatment-resistant depression: a pilot clinical trial Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/20451253251377187 PubMed 41050149 Copy citation Copy BibTeX Therapeutic Advances in Psychopharmacology 2025-08-31 Sally Meikle, Olivia Carter, Paul Liknaitzky, Lauren Johansen, Ravi Iyer, Nigel Strauss OpenAlex Published psilocybin DepressionChronic PainSpirituality Clinical Trial More
Select for export Psilocybin-assisted therapy for treatment-resistant depression in the US: a model-based cost-effectiveness analysis Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41398-025-03556-4 PubMed 40883271 Copy citation Copy BibTeX Translational Psychiatry 2025-08-28 Anton L.V. Avanceña, Linh N. Vuong, James G. Kahn, Elliot Marseille OpenAlex Published psilocybin DepressionReceptor PharmacologyTreatment-Resistant Depression Other More
Select for export Investigating the safety and tolerability of single-dose psilocybin for post-traumatic stress disorder: A nonrandomized open-label clinical trial Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811251362390 PubMed 40883964 Copy citation Copy BibTeX Journal of Psychopharmacology 2025-08-28 Niall M. McGowan, James Rucker, Rachel Yehuda, Manish Agrawal, Nadav Liam Modlin, Hollie Simmons OpenAlex Published psilocybin DepressionPTSDChronic Pain Clinical Trial More
Select for export Overview and Specificity of Psilocybin Use in the Treatment of Mental Disorders: A Scientometric Analysis. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1089/psymed.2024.0031 PubMed 40933206 Copy citation Copy BibTeX Unknown journal 2025-08-27 Fernandes-Nascimento MH, Viana-Ferreira K, Negrão AB. Europe PMC Published psilocybin DepressionAnxietyAddiction Clinical Trial More
Select for export Psilocybin: Systematic review of its use in the treatment of depression No abstract availability was recorded for this entry. Details Copy citation Copy BibTeX Unknown journal 2025-08-25 Andres-Olivera P, de la Iglesia J, Dominguez-Alvarez E, Soto’Gonzalez P, Rodriguez C, Munaiz-Cossio C Europe PMC Published psilocybin DepressionSystematic ReviewReview Article Systematic Review More
Select for export “To Have the Encounter with Our Own Finiteness in that Existential Way”: Descriptions of Existential Experience in Patients with Cancer and Major Depression Participating in Psilocybin-Assisted Group Therapy Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/28314425251370303 Copy citation Copy BibTeX Psychedelic Medicine 2025-08-24 Elise C. Tarbi, Skye A. Miner, Kabir Nigam, Zachary Sager, Justin J. Sanders, Michael Ljuslin OpenAlex Published psilocybin DepressionSpiritualityClinical Trial Clinical Trial More
Select for export Above the threshold, beyond the trip: the role of the 5-HT2A receptor in psychedelic-induced neuroplasticity and antidepressant effects. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41380-025-03169-9 PubMed 40849544 Copy citation Copy BibTeX Unknown journal 2025-08-22 Drewko AJ, Habets RLP, Brunt TM. Europe PMC Published psilocybin DepressionNeuroplasticityMechanism of Action Review Article More
Select for export Psychedelic Therapy, Positive Emotional Experiences, and the Central Role of Self-Compassion Abstract available at the source but not redistributed here. Read at source. Details DOI 10.21203/rs.3.rs-7420529/v1 Copy citation Copy BibTeX Research Square 2025-08-21 Zeifman R, Danias G, Agin-Liebes G, Pagni B, Kettner H, Bhat V Europe PMC PREPRINT (not peer reviewed) psilocybin DepressionEmotional ProcessingMystical Experience Clinical Trial More
Select for export Chronic psilocybin administration increases sociability and alters the gut microbiome in male wild-type mice but not in a preclinical model of obsessive-compulsive disorder Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.neuropharm.2025.110648 PubMed 40849086 Copy citation Copy BibTeX Neuropharmacology 2025-08-20 James J Gattuso, Geraldine Kong, Bilgenur Bezcioglu, Da Lu, Millicent N. Ekwudo, Carey Wilson OpenAlex Published psilocybin DepressionAnxietyOCD Animal Study More
Select for export Effect of Psilocybin on the Positive Valence System in Treatment-resistant Depression: a Pilot Clinical Neuroimaging Study Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2025-08-19 Centre Hospitalier Universitaire de Nīmes ClinicalTrials.gov CLINICAL TRIAL psilocybinpsilocin DepressionBrain ImagingMechanism of Action Other More
Select for export Psilocybin-assisted psychotherapy, combined antipsychotic and antidepressant treatment for bipolar depression, duration of birth control pill use and risk of depression, handgrip strength and cognitive function, mood disorders in epilepsy, and mental health issues among physicians. No abstract availability was recorded for this entry. Details DOI 10.1177/00912174251369880 PubMed 40833259 Copy citation Copy BibTeX Unknown journal 2025-08-19 Koenig HG. Europe PMC Published psilocybin DepressionSafety Other More
Select for export A Phase II, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of COMP360 in Participants With Recurrent Major Depressive Disorder Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2025-08-18 COMPASS Pathways ClinicalTrials.gov CLINICAL TRIAL psilocybin DepressionPharmacologyClinical Trial Clinical Trial More
Select for export Exploring the Therapeutic Potential of Ketamine and Psilocybin in Comparison to Current Treatment Regimens for Treatment-Resistant Depression, Mood Disorders, and Post-traumatic Stress Disorder in the Pediatric Population: A Narrative Review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.7759/cureus.90425 PubMed 40970030 Copy citation Copy BibTeX Unknown journal 2025-08-17 Hughes B, Mirza S, Ponamala M, Sagaser J, Paredes R, Hematillake N Europe PMC Published psilocybin DepressionAnxietyPTSD Meta-Analysis More
Select for export Psilocybin treatment for symptoms of depression: a living systematic review, meta-analysis, and data resource Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2025.08.13.25333530 Copy citation Copy BibTeX medRxiv 2025-08-15 Singleton SP, Sevchik BL, Lahey A, Cuijpers P, Harrer M, Jones MT medRxiv PREPRINT (not peer reviewed) psilocybin DepressionClinical TrialRandomized Controlled Trial Randomized Controlled Trial More
Select for export Therapeutic Divergence in 5-HT2A Agonism: Psilocybin and Phenalkylamines for Demoralization Syndrome. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1021/acsmedchemlett.5c00475 PubMed 40959252 Copy citation Copy BibTeX Unknown journal 2025-08-14 Kargbo RB. Europe PMC Published psilocybin DepressionReceptor PharmacologySafety Other More
Select for export Hallucinogen-Persisting Perception Disorder in a 16-Year-Old Adolescent Abstract available at the source but not redistributed here. Read at source. Details DOI 10.64719/pb.4525 PubMed 39935673 Copy citation Copy BibTeX Psychopharmacology Bulletin 2025-08-11 Anna Mori-Kreiner, Arpit Aggarwal, Meelie Bordoloi OpenAlex Published psilocybin DepressionAddictionReview Article Review Article More
Select for export Psilocybin-assisted psychotherapy for depression and anxiety associated with life threatening illness: A phase 2b randomized controlled trial Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.genhosppsych.2025.08.001 PubMed 40858059 Copy citation Copy BibTeX General Hospital Psychiatry 2025-08-11 Margaret Ross, Ravi Iyer, M.L. Williams, Mark Boughey, Clare O’Callaghan, Richard Hiscock OpenAlex Published psilocybin DepressionAnxietyEnd-of-Life Distress Randomized Controlled Trial More